Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Other financing activities: 2009-2024

Historic Other financing activities for Gyre Therapeutics (GYRE) over the last 7 years, with Dec 2024 value amounting to $536,000.

  • Gyre Therapeutics' Other financing activities fell 730.00% to -$315,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 75.66%. This contributed to the annual value of $536,000 for FY2024, which is N/A change from last year.
  • Gyre Therapeutics' Other financing activities amounted to $536,000 in FY2024, which was down 96.26% from $14.3 million recorded in FY2017.
  • Gyre Therapeutics' Other financing activities' 5-year high stood at $536,000 during FY2024, with a 5-year trough of $536,000 in FY2024.
  • Moreover, its 1-year median value for Other financing activities was $536,000 (2024), whereas its average is $536,000.